Evofem Biosciences, Inc. Made Headway
Evofem Biosciences, Inc. (EVFM:NASDAQ) shot up at $0.13, representing a gain of 41.3%. On Wed, Oct 26, 2022, EVFM:NASDAQ hit a New 2-Week High of $0.13. The stock got featured on our News Catalysts scanner on Wed, Oct 12, 2022 at 03:15 AM in the 'BIOTECH' category. From Wed, Oct 12, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Aug 05, 2022 at $1.11 with a volume of 39M+.
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- ESSA Pharma Inc. (EPIX:NASDAQ), 180.23%
- OneConnect Financial Technology Co., Ltd. (OCFT:NYSE), 45.78%
- RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A (RLX:NYSE), 42.98%
- Cipher Mining Inc. (CIFR:NASDAQ), 42.56%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 41.3%
- Loyalty Ventures Inc. (LYLT:NASDAQ), 39.6%
- EQONEX LIMITED (EQOS:NASDAQ), 38.24%
- Freight Technologies Inc Com (FRGT:NASDAQ), 37.44%
- Femasys Inc. (FEMY:NASDAQ), 33.02%
- LMF Acquisition Opportunities Inc. (LMAO:NASDAQ), 30.25%